Page 1 of Clinical Trials for antitumor immunotherapy, 95 Total Matches
- 1Active, not recruitingLast Updated: January 12, 2011Condition(s): Melanoma
- 2RecruitingLast Updated: January 9, 2012Condition(s): Neuroblastoma
- 3Active, not recruitingLast Updated: September 8, 2011Condition(s): Brain and Central Nervous System Tumors
- 4Active, not recruitingLast Updated: September 8, 2011Condition(s): Brain and Central Nervous System Tumors
- 5RecruitingLast Updated: December 26, 2011Condition(s): Hematological Malignancy
- 6CompletedLast Updated: January 21, 2011Condition(s): Hematologic Neoplasms; Relapse
- 7RecruitingLast Updated: August 8, 2008Condition(s): Normal Full-Term Deliveries
- 8RecruitingLast Updated: January 30, 2012Condition(s): Breast Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
- 9RecruitingLast Updated: August 12, 2011Condition(s): Nasopharyngeal Carcinoma
- 10RecruitingLast Updated: June 6, 2011Condition(s): Hematological Malignancy; Leukemia; Lymphoma; Multiple Myeloma
- 11CompletedLast Updated: May 5, 2010Condition(s): Ovarian Cancer; Peritoneal Cavity Cancer
- 12Active, not recruitingLast Updated: June 23, 2005Condition(s): Prostate Cancer
- 13Not yet recruitingLast Updated: November 12, 2010Condition(s): Renal Cell Carcinoma
- 14CompletedLast Updated: April 21, 2011Condition(s): Recurrent Melanoma; Stage IV Melanoma
- 15Not yet recruitingLast Updated: February 1, 2012Condition(s): HER2+ Cancer
- 16RecruitingLast Updated: December 19, 2005Condition(s): Cervical Cancer
- 17Active, not recruitingLast Updated: January 19, 2012Condition(s): Melanoma; Malignant Melanoma; Melanoma, Experimental; Experimental Melanomas
- 18CompletedLast Updated: December 30, 2011Condition(s): Ewing's Sarcoma; Rhabdomyosarcoma
- 19RecruitingLast Updated: December 30, 2011Condition(s): Skin Cancer; Melanoma; Metastatic Melanoma
- 20RecruitingLast Updated: November 23, 2011Condition(s): Non-small Cell Lung Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=antitumor+immunotherapy
